General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kaliner MA et al. - No significant between-treatment differences were determined for the average 2-week percent changes from baseline for congestion, runny nose, sneezing, itchy nose, and ocular symptoms, although olopatadine had a faster onset of action for reducing all symptoms. Both treatments were safe and well tolerated. Olopatadine and fluticasone nasal sprays both reduced nasal and ocular SAR symptoms with no significant between-treatment differences except for a faster and greater onset of action with olopatadine.


Today in Allergy...keeping you current

Allergic rhinitis with negative skin tests: Does it exist
Allergy and Asthma Proceedings, 10/13/09

Objective assessments of allergic and nonallergic rhinitis in young children
Allergy, 09/21/09

Oral Allergy Syndrome
Allergology International, 10/30/09

Today in Clinical Pharmacology...keeping you current

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09

Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 10/13/09

Otitis media and antihistamines
Current Allergy and Asthma Reports, 10/22/09

Today in Nose...keeping you current

Allergic rhinitis with negative skin tests: Does it exist
Allergy and Asthma Proceedings, 10/13/09

Objective assessments of allergic and nonallergic rhinitis in young children
Allergy, 09/21/09

Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address